TGM2
TGM2 (transglutaminase 2, also known as TG2 or TGC) is a calcium-dependent enzyme of the transglutaminase family that crosslinks proteins through isopeptide bonds. It is also able to induce apoptosis independently of its acyltransferase activity. Browse Assay Genie's current range of TGM2 research reagents below, or read on for the biology behind the target.
TGM2 belongs to the transglutaminase superfamily, whose members catalyse the crosslinking of proteins by epsilon-gamma glutamyl lysine isopeptide bonds. Their activity is calcium-dependent. Although the primary structure of transglutaminases is not conserved, they all share the same amino acid sequence at their active sites. The TGM2 protein acts as a monomer. UniProt also annotates a cytotoxic activity: TGM2 is able to induce apoptosis independently of its acyltransferase activity, and the NCBI Gene summary describes it as appearing to be involved in apoptosis.
The TGM2 gene encodes protein-glutamine gamma-glutamyltransferase 2, classified by HGNC in the transglutaminases gene group. Its expression is induced by retinoic acid. UniProt records a broad subcellular distribution: cytosol, perinuclear cytoplasm, nucleus, chromosome, mitochondrion, cell membrane, and the secreted extracellular matrix. Two transcript variants encoding different isoforms have been reported for the gene. Mouse and rat both carry an orthologue named Tgm2, which allows the protein to be studied in common rodent models.
The previous HGNC name, transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase), explains the alias TGC; TG2 is the other commonly used short name. TGM2 is of particular clinical interest because the encoded protein is the autoantigen implicated in celiac disease. Researchers working with a TGM2 antibody, TGM2 ELISA kit or recombinant TGM2 protein typically study its crosslinking activity, its role in cell death and its function in autoimmunity.
TGM2 is the autoantigen implicated in celiac disease, making it a central protein in studies of this autoimmune condition.
TGM2 can induce apoptosis independently of its acyltransferase activity, and is linked to apoptotic processes.
As a calcium-dependent transglutaminase, TGM2 forms epsilon-gamma glutamyl lysine isopeptide bonds between proteins.
TGM2 is induced by retinoic acid, so it is used as a readout in studies of retinoid-responsive gene expression.
TGM2 is a calcium-dependent transglutaminase that catalyses protein crosslinking through epsilon-gamma glutamyl lysine isopeptide bonds. It also has cytotoxic activity and can induce apoptosis independently of its acyltransferase activity. It acts as a monomer, and retinoic acid induces its expression.
TGM2 is also called TG2 and TGC. The HGNC full name is transglutaminase 2, formerly transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase). UniProt names it protein-glutamine gamma-glutamyltransferase 2. Two transcript variants encoding different isoforms have been reported for the gene.
The TGM2 protein is the autoantigen implicated in celiac disease. Mouse and rat each have an orthologue called Tgm2, so rodent models can be used for functional work. Check the datasheet of any product for its validated reactivity.
Other members of the transglutaminase family that share the conserved active-site sequence and calcium-dependent crosslinking activity.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P21980; product specifications from Assay Genie datasheets.